English

Fulgent Genetics, Inc.

EDGAR

FLGT Quarterly report (10-Q) · filed 2026-07-30

Annual consolidated revenue for 2025: about USD 322.7M, using the latest reported figures. The previous period, 2024, was about USD 283.5M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

85.4 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 85389000 USD Source

Operating margin

-42.25%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -36073000 USD Source
Revenue: 85389000 USD Source

Operating cash flow

-23.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -16661000 USD Source
Operating Cash Flow: 7097000 USD Source

Free cash flow

-27.6 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -16661000 USD Source
Operating Cash Flow: 7097000 USD Source
Capital Expenditure: 9060000 USD Source
Capital Expenditure: 5202000 USD Source

Cash and cash equivalents: 26.3 million USD 2026-06-30 Source
Exact value

26305000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 27.5 million shares 2026-06-30 Source
Exact value

27515000 shares

Reported share-count change

-10.11% · -3.09 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30608000 shares · 2025-06-30· Source
27515000 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

324 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 84069000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 322671000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 239335000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 71138000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 85389000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-84.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -6608000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -60513000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -37095000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -24826000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -29530000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-83.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -23495000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -34602000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -101638000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -23495000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 7097000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -16661000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 7097000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

20.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 17594000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 11544000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 22574000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 17594000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5202000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 9060000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5202000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-104 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -23495000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -34602000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -101638000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -23495000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 7097000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -16661000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 7097000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 17594000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 11544000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 22574000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 17594000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5202000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 9060000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5202000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-07-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+13.8%

Prior period

USD 283.47 million

2024-01-01 – 2024-12-31
Current period

USD 322.67 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

322671000 − 283470000 = 39201000 USD

283470000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
322671000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Year-over-year change in Revenue: 39201000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 322671000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#3993251 Filing: 000119312526079169 Input fundies:Revenue: 283470000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#4035785 Filing: 000119312526079169
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 17.81 million

Prior period

−USD 42.71 million

2024-01-01 – 2024-12-31
Current period

−USD 60.51 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-60513000 − -42708000 = -17805000 USD

-42708000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-60513000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Year-over-year change in Net income: -17805000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -60513000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2269344 Filing: 000119312526079169 Input fundies:NetIncome: -42708000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2271188 Filing: 000119312526079169
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-582.6%

Prior period

USD 21.06 million

2024-01-01 – 2024-12-31
Current period

−USD 101.64 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-101638000 − 21060000 = -122698000 USD

21060000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-101638000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Year-over-year change in Operating cash flow: -122698000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -101638000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2897690 Filing: 000119312526079169 Input fundies:OperatingCashFlow: 21060000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2899461 Filing: 000119312526079169
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-44%

Prior period

USD 40.32 million

2024-01-01 – 2024-12-31
Current period

USD 22.57 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

22574000 − 40315000 = -17741000 USD

40315000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
22574000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Year-over-year change in Capital expenditure: -17741000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 22574000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2912869 Filing: 000119312526079169 Input fundies:CapitalExpenditure: 40315000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2914638 Filing: 000119312526079169
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 322.67 million 100% of revenue
Cost of revenue USD 191.8 million 59% of revenue
Operating expenses USD 221.97 million 69% of revenue
Operating income −USD 91.1 million −28% of revenue
Tax, interest and other Derived −USD 30.58 million −9.5% of revenue
Net income −USD 60.51 million −19% of revenue

Cash

Operating cash flow −USD 101.64 million −31% of revenue
Capital expenditure USD 22.57 million 7% of revenue
Free cash flow Derived −USD 124.21 million −38% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Net loss: net income was −29% of revenue.
2017 Operating loss: operating costs were 119% of revenue.
2018 Operating loss: operating costs were 124% of revenue.
2019 Operating loss: operating costs were 101% of revenue.
2020 51%18%31%
2021 51%17%32%
2022 23%71%
2023 Operating loss: operating costs were 168% of revenue.
2024 Operating loss: operating costs were 126% of revenue.
2025 Operating loss: operating costs were 128% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	18276000	17358000 Derived	918000	6265000 Derived	-5347000	617000 Derived	Source 2016-01-01 – 2016-12-31: 18276000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 918000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -5347000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 4405000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 3788000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	18730000	22212000 Derived	-3482000	-972000 Derived	-2510000	-1564000 Derived	Source 2017-01-01 – 2017-12-31: 18730000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -3482000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -2510000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 1331000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2895000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	21351000	26421000 Derived	-5070000	537000 Derived	-5607000	-2997000 Derived	Source 2018-01-01 – 2018-12-31: 21351000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -5070000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -5607000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -675000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 2322000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	32528000	32956000 Derived	-428000	-17000 Derived	-411000	4335000 Derived	Source 2019-01-01 – 2019-12-31: 32528000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -428000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -411000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 5517000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1182000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	421712000	131554000 Derived	290158000	75848000 Derived	214310000	105498000 Derived	Source 2020-01-01 – 2020-12-31: 421712000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 290158000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 214310000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 140628000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 35130000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	992584000	316631000 Derived	675953000	168589000 Derived	507364000	514765000 Derived	Source 2021-01-01 – 2021-12-31: 992584000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 675953000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 507364000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 538577000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 23812000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	618968000	440441000 Derived	178527000	35124000 Derived	143403000	234745000 Derived	Source 2022-01-01 – 2022-12-31: 618968000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 178527000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 143403000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 253520000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 18775000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	289213000	484742000 Derived	-195529000	-27704000 Derived	-167825000	4796000 Derived	Source 2023-01-01 – 2023-12-31: 289213000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -195529000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -167825000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 27003000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 22207000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	283470000	357388000 Derived	-73918000	-31210000 Derived	-42708000	-19255000 Derived	Source 2024-01-01 – 2024-12-31: 283470000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -73918000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -42708000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 21060000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 40315000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	322671000	413767000 Derived	-91096000	-30583000 Derived	-60513000	-124212000 Derived	Source 2025-01-01 – 2025-12-31: 322671000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -91096000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -60513000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -101638000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 22574000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 322.7M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	18276000	Revenue: 18276000 Open source
20172017-12-31	Revenue	18730000	Revenue: 18730000 Open source
20182018-12-31	Revenue	21351000	Revenue: 21351000 Open source
20192019-12-31	Revenue	32528000	Revenue: 32528000 Open source
20202020-12-31	Revenue	421712000	Revenue: 421712000 Open source
20212021-12-31	Revenue	992584000	Revenue: 992584000 Open source
20222022-12-31	Revenue	618968000	Revenue: 618968000 Open source
20232023-12-31	Revenue	289213000	Revenue: 289213000 Open source
20242024-12-31	Revenue	283470000	Revenue: 283470000 Open source
20252025-12-31	Revenue	322671000	Revenue: 322671000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

13.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	90.9%	Revenue: 18276000 Open source Revenue: 9576000 Open source
20172017-12-31	Year over year	2.5%	Revenue: 18730000 Open source Revenue: 18276000 Open source
20182018-12-31	Year over year	14%	Revenue: 21351000 Open source Revenue: 18730000 Open source
20192019-12-31	Year over year	52.3%	Revenue: 32528000 Open source Revenue: 21351000 Open source
20202020-12-31	Year over year	1,196.5%	Revenue: 421712000 Open source Revenue: 32528000 Open source
20212021-12-31	Year over year	135.4%	Revenue: 992584000 Open source Revenue: 421712000 Open source
20222022-12-31	Year over year	-37.6%	Revenue: 618968000 Open source Revenue: 992584000 Open source
20232023-12-31	Year over year	-53.3%	Revenue: 289213000 Open source Revenue: 618968000 Open source
20242024-12-31	Year over year	-2%	Revenue: 283470000 Open source Revenue: 289213000 Open source
20252025-12-31	Year over year	13.8%	Revenue: 322671000 Open source Revenue: 283470000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -28.2% 2025

Net margin -18.8% 2025

Free cash flow margin -38.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	5%	Operating Income: 918000 Open source Revenue: 18276000 Open source
20172017-12-31	Operating margin	-18.6%	Operating Income: -3482000 Open source Revenue: 18730000 Open source
20182018-12-31	Operating margin	-23.7%	Operating Income: -5070000 Open source Revenue: 21351000 Open source
20192019-12-31	Operating margin	-1.3%	Operating Income: -428000 Open source Revenue: 32528000 Open source
20202020-12-31	Operating margin	68.8%	Operating Income: 290158000 Open source Revenue: 421712000 Open source
20212021-12-31	Operating margin	68.1%	Operating Income: 675953000 Open source Revenue: 992584000 Open source
20222022-12-31	Operating margin	28.8%	Operating Income: 178527000 Open source Revenue: 618968000 Open source
20232023-12-31	Operating margin	-67.6%	Operating Income: -195529000 Open source Revenue: 289213000 Open source
20242024-12-31	Operating margin	-26.1%	Operating Income: -73918000 Open source Revenue: 283470000 Open source
20252025-12-31	Operating margin	-28.2%	Operating Income: -91096000 Open source Revenue: 322671000 Open source
20162016-12-31	Net margin	-29.3%	Net Income: -5347000 Open source Revenue: 18276000 Open source
20172017-12-31	Net margin	-13.4%	Net Income: -2510000 Open source Revenue: 18730000 Open source
20182018-12-31	Net margin	-26.3%	Net Income: -5607000 Open source Revenue: 21351000 Open source
20192019-12-31	Net margin	-1.3%	Net Income: -411000 Open source Revenue: 32528000 Open source
20202020-12-31	Net margin	50.8%	Net Income: 214310000 Open source Revenue: 421712000 Open source
20212021-12-31	Net margin	51.1%	Net Income: 507364000 Open source Revenue: 992584000 Open source
20222022-12-31	Net margin	23.2%	Net Income: 143403000 Open source Revenue: 618968000 Open source
20232023-12-31	Net margin	-58%	Net Income: -167825000 Open source Revenue: 289213000 Open source
20242024-12-31	Net margin	-15.1%	Net Income: -42708000 Open source Revenue: 283470000 Open source
20252025-12-31	Net margin	-18.8%	Net Income: -60513000 Open source Revenue: 322671000 Open source
20162016-12-31	Free cash flow margin	3.4%	Revenue: 18276000 Open source Operating Cash Flow: 4405000 Open source Capital Expenditure: 3788000 Open source
20172017-12-31	Free cash flow margin	-8.4%	Revenue: 18730000 Open source Operating Cash Flow: 1331000 Open source Capital Expenditure: 2895000 Open source
20182018-12-31	Free cash flow margin	-14%	Revenue: 21351000 Open source Operating Cash Flow: -675000 Open source Capital Expenditure: 2322000 Open source
20192019-12-31	Free cash flow margin	13.3%	Revenue: 32528000 Open source Operating Cash Flow: 5517000 Open source Capital Expenditure: 1182000 Open source
20202020-12-31	Free cash flow margin	25%	Revenue: 421712000 Open source Operating Cash Flow: 140628000 Open source Capital Expenditure: 35130000 Open source
20212021-12-31	Free cash flow margin	51.9%	Revenue: 992584000 Open source Operating Cash Flow: 538577000 Open source Capital Expenditure: 23812000 Open source
20222022-12-31	Free cash flow margin	37.9%	Revenue: 618968000 Open source Operating Cash Flow: 253520000 Open source Capital Expenditure: 18775000 Open source
20232023-12-31	Free cash flow margin	1.7%	Revenue: 289213000 Open source Operating Cash Flow: 27003000 Open source Capital Expenditure: 22207000 Open source
20242024-12-31	Free cash flow margin	-6.8%	Revenue: 283470000 Open source Operating Cash Flow: 21060000 Open source Capital Expenditure: 40315000 Open source
20252025-12-31	Free cash flow margin	-38.5%	Revenue: 322671000 Open source Operating Cash Flow: -101638000 Open source Capital Expenditure: 22574000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -101.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	4405000	Operating Cash Flow: 4405000 Open source
20172017-12-31	Operating cash flow	1331000	Operating Cash Flow: 1331000 Open source
20182018-12-31	Operating cash flow	-675000	Operating Cash Flow: -675000 Open source
20192019-12-31	Operating cash flow	5517000	Operating Cash Flow: 5517000 Open source
20202020-12-31	Operating cash flow	140628000	Operating Cash Flow: 140628000 Open source
20212021-12-31	Operating cash flow	538577000	Operating Cash Flow: 538577000 Open source
20222022-12-31	Operating cash flow	253520000	Operating Cash Flow: 253520000 Open source
20232023-12-31	Operating cash flow	27003000	Operating Cash Flow: 27003000 Open source
20242024-12-31	Operating cash flow	21060000	Operating Cash Flow: 21060000 Open source
20252025-12-31	Operating cash flow	-101638000	Operating Cash Flow: -101638000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -124.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	617000	Operating Cash Flow: 4405000 Open source Capital Expenditure: 3788000 Open source
20172017-12-31	Free cash flow	-1564000	Operating Cash Flow: 1331000 Open source Capital Expenditure: 2895000 Open source
20182018-12-31	Free cash flow	-2997000	Operating Cash Flow: -675000 Open source Capital Expenditure: 2322000 Open source
20192019-12-31	Free cash flow	4335000	Operating Cash Flow: 5517000 Open source Capital Expenditure: 1182000 Open source
20202020-12-31	Free cash flow	105498000	Operating Cash Flow: 140628000 Open source Capital Expenditure: 35130000 Open source
20212021-12-31	Free cash flow	514765000	Operating Cash Flow: 538577000 Open source Capital Expenditure: 23812000 Open source
20222022-12-31	Free cash flow	234745000	Operating Cash Flow: 253520000 Open source Capital Expenditure: 18775000 Open source
20232023-12-31	Free cash flow	4796000	Operating Cash Flow: 27003000 Open source Capital Expenditure: 22207000 Open source
20242024-12-31	Free cash flow	-19255000	Operating Cash Flow: 21060000 Open source Capital Expenditure: 40315000 Open source
20252025-12-31	Free cash flow	-124212000	Operating Cash Flow: -101638000 Open source Capital Expenditure: 22574000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

8.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	6.1%	Total Liabilities: 3561000 Open source Total Assets: 58040000 Open source
20172017-12-31	Liabilities / assets	5.3%	Total Liabilities: 3006000 Open source Total Assets: 57184000 Open source
20182018-12-31	Liabilities / assets	5.1%	Total Liabilities: 2752000 Open source Total Assets: 53904000 Open source
20192019-12-31	Liabilities / assets	6.7%	Total Liabilities: 5979000 Open source Total Assets: 88756000 Open source
20202020-12-31	Liabilities / assets	18.7%	Total Liabilities: 131074000 Open source Total Assets: 700461000 Open source
20212021-12-31	Liabilities / assets	8.8%	Total Liabilities: 112840000 Open source Total Assets: 1278720000 Open source
20222022-12-31	Liabilities / assets	8.4%	Total Liabilities: 116178000 Open source Total Assets: 1386053000 Open source
20232023-12-31	Liabilities / assets	8.3%	Total Liabilities: 102042000 Open source Total Assets: 1235328000 Open source
20242024-12-31	Liabilities / assets	7.4%	Total Liabilities: 90805000 Open source Total Assets: 1219964000 Open source
20252025-12-31	Liabilities / assets	8.8%	Total Liabilities: 106810000 Open source Total Assets: 1213525000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.48× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	7.88×	Current Assets: 26138000 Open source Current Liabilities: 3316000 Open source
20172017-12-31	Current assets / current liabilities	10.98×	Current Assets: 32927000 Open source Current Liabilities: 3000000 Open source
20182018-12-31	Current assets / current liabilities	14.44×	Current Assets: 39543000 Open source Current Liabilities: 2738000 Open source
20192019-12-31	Current assets / current liabilities	9.96×	Current Assets: 37079000 Open source Current Liabilities: 3723000 Open source
20202020-12-31	Current assets / current liabilities	4.02×	Current Assets: 523616000 Open source Current Liabilities: 130115000 Open source
20212021-12-31	Current assets / current liabilities	5.81×	Current Assets: 611960000 Open source Current Liabilities: 105310000 Open source
20222022-12-31	Current assets / current liabilities	7.13×	Current Assets: 627873000 Open source Current Liabilities: 88107000 Open source
20232023-12-31	Current assets / current liabilities	6.96×	Current Assets: 507845000 Open source Current Liabilities: 73018000 Open source
20242024-12-31	Current assets / current liabilities	4.85×	Current Assets: 353571000 Open source Current Liabilities: 72899000 Open source
20252025-12-31	Current assets / current liabilities	6.48×	Current Assets: 550490000 Open source Current Liabilities: 84967000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 5.35 million Exact value Exact value: -5347000 USD 2016-01-01 – 2016-12-31: -5347000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2016-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -5347000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5347000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459018006239/flgt-20171231.xml#138703 Filing: 000156459018006239 The citation records this snapshot. The page link may show a newer release later.	USD 4.41 million Exact value Exact value: 4405000 USD 2016-01-01 – 2016-12-31: 4405000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2016-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 4405000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4405000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459018006239/flgt-20171231.xml#163098 Filing: 000156459018006239 The citation records this snapshot. The page link may show a newer release later.	USD 3.79 million Exact value Exact value: 3788000 USD 2016-01-01 – 2016-12-31: 3788000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2016-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 3788000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3788000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459018006239/flgt-20171231.xml#163518 Filing: 000156459018006239 The citation records this snapshot. The page link may show a newer release later.	USD 617,000 Calculation and evidence 4405000 − 3788000 USD Exact free cash flow: 617000 USD 2016-01-01 – 2016-12-31: 4405000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 3788000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2016-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 617000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4405000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459018006239/flgt-20171231.xml#163098 Filing: 000156459018006239 Input fundies:CapitalExpenditure: 3788000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459018006239/flgt-20171231.xml#163518 Filing: 000156459018006239 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 2.51 million Exact value Exact value: -2510000 USD 2017-01-01 – 2017-12-31: -2510000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2017-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -2510000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2510000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459019008991/flgt-20181231.xml#126190 Filing: 000156459019008991 The citation records this snapshot. The page link may show a newer release later.	USD 1.33 million Exact value Exact value: 1331000 USD 2017-01-01 – 2017-12-31: 1331000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2017-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 1331000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1331000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459019008991/flgt-20181231.xml#143387 Filing: 000156459019008991 The citation records this snapshot. The page link may show a newer release later.	USD 2.9 million Exact value Exact value: 2895000 USD 2017-01-01 – 2017-12-31: 2895000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2017-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 2895000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2895000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459019008991/flgt-20181231.xml#143807 Filing: 000156459019008991 The citation records this snapshot. The page link may show a newer release later.	−USD 1.56 million Calculation and evidence 1331000 − 2895000 USD Exact free cash flow: -1564000 USD 2017-01-01 – 2017-12-31: 1331000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2895000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2017-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: -1564000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1331000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459019008991/flgt-20181231.xml#143387 Filing: 000156459019008991 Input fundies:CapitalExpenditure: 2895000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459019008991/flgt-20181231.xml#143807 Filing: 000156459019008991 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 5.61 million Exact value Exact value: -5607000 USD 2018-01-01 – 2018-12-31: -5607000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2018-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -5607000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5607000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459020010617/flgt-20191231.xml#149292 Filing: 000156459020010617 The citation records this snapshot. The page link may show a newer release later.	−USD 675,000 Exact value Exact value: -675000 USD 2018-01-01 – 2018-12-31: -675000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2018-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: -675000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -675000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459020010617/flgt-20191231.xml#170985 Filing: 000156459020010617 The citation records this snapshot. The page link may show a newer release later.	USD 2.32 million Exact value Exact value: 2322000 USD 2018-01-01 – 2018-12-31: 2322000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2018-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 2322000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2322000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459020010617/flgt-20191231.xml#171405 Filing: 000156459020010617 The citation records this snapshot. The page link may show a newer release later.	−USD 3 million Calculation and evidence -675000 − 2322000 USD Exact free cash flow: -2997000 USD 2018-01-01 – 2018-12-31: -675000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 2322000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2018-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: -2997000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -675000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459020010617/flgt-20191231.xml#170985 Filing: 000156459020010617 Input fundies:CapitalExpenditure: 2322000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459020010617/flgt-20191231.xml#171405 Filing: 000156459020010617 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 411,000 Exact value Exact value: -411000 USD 2019-01-01 – 2019-12-31: -411000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2019-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -411000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -411000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm#4277064 Filing: 000156459022007366 The citation records this snapshot. The page link may show a newer release later.	USD 5.52 million Exact value Exact value: 5517000 USD 2019-01-01 – 2019-12-31: 5517000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2019-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 5517000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5517000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm#2512883 Filing: 000156459022007366 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1182000 USD 2019-01-01 – 2019-12-31: 1182000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2019-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 1182000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1182000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm#2523235 Filing: 000156459022007366 The citation records this snapshot. The page link may show a newer release later.	USD 4.34 million Calculation and evidence 5517000 − 1182000 USD Exact free cash flow: 4335000 USD 2019-01-01 – 2019-12-31: 5517000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1182000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2019-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 4335000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5517000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm#2512883 Filing: 000156459022007366 Input fundies:CapitalExpenditure: 1182000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm#2523235 Filing: 000156459022007366 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 214.31 million Exact value Exact value: 214310000 USD 2020-01-01 – 2020-12-31: 214310000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2020-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: 214310000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 214310000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm#5068300 Filing: 000095017023005178 The citation records this snapshot. The page link may show a newer release later.	USD 140.63 million Exact value Exact value: 140628000 USD 2020-01-01 – 2020-12-31: 140628000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2020-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 140628000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 140628000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm#2964661 Filing: 000095017023005178 The citation records this snapshot. The page link may show a newer release later.	USD 35.13 million Exact value Exact value: 35130000 USD 2020-01-01 – 2020-12-31: 35130000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2020-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 35130000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35130000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm#2975230 Filing: 000095017023005178 The citation records this snapshot. The page link may show a newer release later.	USD 105.5 million Calculation and evidence 140628000 − 35130000 USD Exact free cash flow: 105498000 USD 2020-01-01 – 2020-12-31: 140628000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 35130000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2020-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 105498000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 140628000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm#2964661 Filing: 000095017023005178 Input fundies:CapitalExpenditure: 35130000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm#2975230 Filing: 000095017023005178 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 507.36 million Exact value Exact value: 507364000 USD 2021-01-01 – 2021-12-31: 507364000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2021-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: 507364000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 507364000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm#1963715 Filing: 000095017024022233 The citation records this snapshot. The page link may show a newer release later.	USD 538.58 million Exact value Exact value: 538577000 USD 2021-01-01 – 2021-12-31: 538577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2021-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 538577000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 538577000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm#2415779 Filing: 000095017024022233 The citation records this snapshot. The page link may show a newer release later.	USD 23.81 million Exact value Exact value: 23812000 USD 2021-01-01 – 2021-12-31: 23812000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2021-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 23812000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23812000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm#2422288 Filing: 000095017024022233 The citation records this snapshot. The page link may show a newer release later.	USD 514.77 million Calculation and evidence 538577000 − 23812000 USD Exact free cash flow: 514765000 USD 2021-01-01 – 2021-12-31: 538577000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 23812000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2021-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 514765000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 538577000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm#2415779 Filing: 000095017024022233 Input fundies:CapitalExpenditure: 23812000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm#2422288 Filing: 000095017024022233 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 143.4 million Exact value Exact value: 143403000 USD 2022-01-01 – 2022-12-31: 143403000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2022-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: 143403000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 143403000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm#2276227 Filing: 000095017025029512 The citation records this snapshot. The page link may show a newer release later.	USD 253.52 million Exact value Exact value: 253520000 USD 2022-01-01 – 2022-12-31: 253520000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2022-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 253520000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 253520000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm#2854253 Filing: 000095017025029512 The citation records this snapshot. The page link may show a newer release later.	USD 18.78 million Exact value Exact value: 18775000 USD 2022-01-01 – 2022-12-31: 18775000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2022-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 18775000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18775000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm#2868635 Filing: 000095017025029512 The citation records this snapshot. The page link may show a newer release later.	USD 234.75 million Calculation and evidence 253520000 − 18775000 USD Exact free cash flow: 234745000 USD 2022-01-01 – 2022-12-31: 253520000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 18775000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2022-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 234745000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 253520000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm#2854253 Filing: 000095017025029512 Input fundies:CapitalExpenditure: 18775000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm#2868635 Filing: 000095017025029512 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 167.83 million Exact value Exact value: -167825000 USD 2023-01-01 – 2023-12-31: -167825000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2023-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -167825000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -167825000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2273032 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 27 million Exact value Exact value: 27003000 USD 2023-01-01 – 2023-12-31: 27003000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2023-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 27003000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27003000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2901213 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 22.21 million Exact value Exact value: 22207000 USD 2023-01-01 – 2023-12-31: 22207000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2023-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 22207000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22207000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2916407 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 4.8 million Calculation and evidence 27003000 − 22207000 USD Exact free cash flow: 4796000 USD 2023-01-01 – 2023-12-31: 27003000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 22207000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2023-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: 4796000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27003000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2901213 Filing: 000119312526079169 Input fundies:CapitalExpenditure: 22207000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2916407 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 42.71 million Exact value Exact value: -42708000 USD 2024-01-01 – 2024-12-31: -42708000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2024-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -42708000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42708000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2271188 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 21.06 million Exact value Exact value: 21060000 USD 2024-01-01 – 2024-12-31: 21060000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2024-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: 21060000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21060000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2899461 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 40.32 million Exact value Exact value: 40315000 USD 2024-01-01 – 2024-12-31: 40315000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2024-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 40315000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 40315000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2914638 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	−USD 19.26 million Calculation and evidence 21060000 − 40315000 USD Exact free cash flow: -19255000 USD 2024-01-01 – 2024-12-31: 21060000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 40315000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2024-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: -19255000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21060000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2899461 Filing: 000119312526079169 Input fundies:CapitalExpenditure: 40315000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2914638 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 60.51 million Exact value Exact value: -60513000 USD 2025-01-01 – 2025-12-31: -60513000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Net Income: -60513000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60513000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2269344 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	−USD 101.64 million Exact value Exact value: -101638000 USD 2025-01-01 – 2025-12-31: -101638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Operating Cash Flow: -101638000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -101638000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2897690 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	USD 22.57 million Exact value Exact value: 22574000 USD 2025-01-01 – 2025-12-31: 22574000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Capital Expenditure: 22574000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22574000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2912869 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.	−USD 124.21 million Calculation and evidence -101638000 − 22574000 USD Exact free cash flow: -124212000 USD 2025-01-01 – 2025-12-31: -101638000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 22574000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fulgent Genetics, Inc. · 2025-12-31 Fulgent Genetics, Inc. (edgar:1674930) Free cash flow: -124212000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:46:56Z Snapshot: ce0e638a8ce3b946e8526d9cb3da02694cd307edac6bbdeeb30523e663ba3cd2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1674930?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -101638000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2897690 Filing: 000119312526079169 Input fundies:CapitalExpenditure: 22574000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm#2912869 Filing: 000119312526079169 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 4,556 latest values · 4,556 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001674930, 1674930, FLGT, edgar:1674930

Also known as FULGENT GENETICS, INC., Fulgent Diagnostics, Inc., Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation